We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,202.60
Bid: 1,202.40
Ask: 1,202.80
Change: -13.40 (-1.10%)
Spread: 0.40 (0.03%)
Open: 1,202.20
High: 1,236.80
Low: 1,201.20
Yest. Close: 1,216.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

China to introduce healthcare corruption "blacklist" in 2014

SHANGHAI, Dec 27 (Reuters) - China will introduce a blacklist of drugmakers and medical device manufacturers found to have paid bribes as it extends a crackdown on graft in the healthcare sector. Healthcare departments will compile lists of offending manufacturers, agents and individuals, w

27 Dec 13 07:38

London close: Stocks surge to two-and-a-half-week high after Fed taper

- FTSE 100 at highest since December 2nd after Fed taper - Fed scales back stimulus, gives guidance on rates - Carnival jumps late on after FY results - Pharmaceutical and life insurance stocks rise techMARK 2,735.02 +1.40% FTSE 100 6,584.70 +1.43% FTSE 250 15,589.95 +1.45% UK stocks surged to a t

19 Dec 13 16:31

FTSE 100 movers: Carnival buoyed by Q4 results, drugmakers higher

Cruise operator Carnival surged into the top spot on the FTSE 100 risers list on Thursday after reporting a smaller-than-expected decline in net revenue yields in the fourth quarter. Net revenue yields in constant dollars fell by 2.1 per cent year-on-year, better than the company's guidance given in

19 Dec 13 14:47

Broker tips: GlaxoSmithKline, Serco, Britvic

Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. "Sandoz/Vectura's EU branded generic of Advair/Seretide was anticipated, though the timing was uncertain. Confirmation of its approval

19 Dec 13 12:23

London midday: Markets jump one per cent after Fed taper

- Fed tapers monthly asset purchases by 10bn dollars - Markets rise, Wall Street hits record high - Annual growth of UK retail sales misses estimates techMARK 2,732.70 +1.31% FTSE 100 6,556.63 +0.99% FTSE 250 15,576.80 +1.37% UK markets had held on to their gains by Thursday lunchtime as investors

19 Dec 13 12:01

Broker snap: Generics threat tightens breathing room at Glaxo, says Jefferies

Jefferies has maintained its 'hold' rating for GlaxoSmithKline (GSK) after Denmark approved the sale of a generic copy of its top-selling inhaled lung drug, Advair. It was announced on Thursday that Novartis' Sandoz and Vectura have been given the green light by Danish authorities for the V315 AirF

19 Dec 13 10:10

London open: Fed taper sparks 'Santa Rally' as stocks jump

- Fed cuts monthly bond buying to 75bn dollars - Commits to near-zero rates, depending on inflation - Pharma peers AstraZeneca, GSK making gains techMARK 2,727.60 +1.12% FTSE 100 6,553.38 +0.94% FTSE 250 15,550.52 +1.20% UK markets opened around one per cent higher on Thursday morning in the after

19 Dec 13 08:17

Glaxo COPD approval cooled by generic Advair competition

US regulators have approved GlaxoSmithKline's treatment for chronic obstructive pulmonary disease, but the excitement was cooled by news that Denmark has approved the sale of a generic copy of GSK's biggest product, Advair. On Wednesday evening Glaxo and Theravance announced that the US Food and Dr

19 Dec 13 07:58

Scientists start to unpick narcolepsy link to GSK flu vaccine

By Kate Kelland LONDON, Dec 18 (Reuters) - Scientists have found that the sleep disorder narcolepsy can sometimes be triggered by a scientific phenomenon known as "molecular mimicry", offering a possible explanation for its link to a GlaxoSmithKline H1N1 pandemic flu vaccine. Results

18 Dec 13 21:11

REFILE-UPDATE 3-Denmark approves generic copy of GSK's top-selling lung drug

(Refiled to improve headline, no change to text) * Green light generic copy of GSK's $8-billion drug Advair * Danish approval is first for product in Europe * Inhaled medicine developed by Vectura and Sandoz * News overshadows U.S. approval for new GSK drug Anoro * G

18 Dec 13 18:11

UPDATE 3-Denmark backs generic lung drug in threat to GSK sales

* Green light generic copy of GSK's $8-billion drug Advair * Danish approval is first for product in Europe * Inhaled medicine developed by Vectura and Sandoz * News overshadows U.S. approval for new GSK drug Anoro * GSK shares fall 1.1 percent, Vectura up 13.4 percent (

18 Dec 13 18:02

FDA approves another GSK, Theravance lung drug

Dec 18 (Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline Plc's new lung drug for treatment of chronic obstructive pulmonary disease (COPD), commonly known as smoker's lung. However, the inhaled treatment, Anoro Ellipta, will carry a warning that one of its component

18 Dec 13 17:05

FTSE 100 movers: Centrica, ARM Holdings, Rexam

Centrica was the top riser on Wednesday after the energy company said it would sell its Texas gas-fired power stations to Blackstone for 685m dollars and use the proceeds to extend its share buyback programme. Chipmaker ARM Holdings gained after Dixons Retail posted sales growth driven by tablet co

18 Dec 13 14:52

UPDATE 2-Denmark backs generic lung drug in threat to GSK sales

* Green light for drug that analysts think is generic Advair * Danish approval is first for product in Europe * Inhaled medicine VR315 developed by Vectura and Sandoz * GSK shares fall 1.5 percent, Vectura up 7.8 percent (Adds comment from analysts and GSK) By Ben Hirsch

18 Dec 13 13:16

UPDATE 1-Denmark backs generic lung drug in threat to GSK sales

(Adds background, shares) LONDON, Dec 18 (Reuters) - Denmark has approved the sale of an inhaled lung drug that analysts think is a generic copy of GlaxoSmithKline's $8 billion-a-year blockbuster Advair, threatening the British drugmaker's future sales. Britain's Vectura said on Wedne

18 Dec 13 12:10

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.